Edition:
United States

Adamis Pharmaceuticals Corp (ADMP.OQ)

ADMP.OQ on NASDAQ Stock Exchange Capital Market

2.99USD
4:00pm EDT
Change (% chg)

$0.09 (+3.10%)
Prev Close
$2.90
Open
$2.90
Day's High
$3.00
Day's Low
$2.83
Volume
59,624
Avg. Vol
152,389
52-wk High
$5.80
52-wk Low
$2.20

Chart for

About

Adamis Pharmaceuticals Corporation is a pharmaceutical company. The Company is engaged in the development of its specialty pharmaceutical products. The Company is developing various products in the allergy and respiratory markets, including a dry powder inhaler technology that it acquired from 3M Company (3M). The Company's... (more)

Overall

Beta: 0.36
Market Cap(Mil.): $146.60
Shares Outstanding(Mil.): 47.29
Dividend: --
Yield (%): --

Financials

  ADMP.OQ Industry Sector
P/E (TTM): -- 29.75 32.14
EPS (TTM): -0.69 -- --
ROI: -69.14 13.18 12.83
ROE: -76.71 15.14 14.95

BRIEF-Adamis Pharmaceuticals Says Working With Sandoz To Prepare Symjepi Launch

* ADAMIS PHARMACEUTICALS - WORKING CLOSELY WITH SANDOZ TO PREPARE A SUCCESSFUL LAUNCH FOR SYMJEPI

Aug 27 2018

BRIEF-Adamis Pharmaceuticals Says Unless Earlier Terminated, Deal With Sandoz Will Expire 10 Yrs From Launch Of Product

* ADAMIS PHARMACEUTICALS - DEAL WITH SANDOZ FOR SYMJEPI PROVIDES SANDOZ WILL PAY TO CO 50% OF NET PROFIT FROM NET SALES OF PRODUCT

Jul 02 2018

Competitors

  Price Chg
GlaxoSmithKline plc (GSK.L) 1,494.40 +8.40

Earnings vs. Estimates